MCINTYRE DAVID enters INHIBIKASE THERAPEUTICS, INC. with 10.29K shares — 100% direct ownership
Full direct ownership at entry is the strongest form of insider alignment with shareholders.
Direct
Filed: 4/16/2025ACC: 0000950170-25-054708
Officer· Chief Financial Officer
Since Apr 2025
10.29K
Baseline shares
100% direct
10.29K
Direct ownership
1 position
0.00
Derivative underlying
0 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned10.29K
Total
10.29K direct10.29K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 10.29K | Direct |
| Total | 10.29K | 10.29K direct |
Derivative Holdings0
No derivative holdings reported